Q2 2026 Sales/Trading Call January 18, 2026 7:30 PM ESTCompany ParticipantsMark Flynn - Investor RelationsThomas Spurling ...

Moon Capital Management identifies Molina Healthcare as a mispriced compounder poised for recovery as Medicaid margins ...

Steady earnings growth drove market returns in 2025 despite global volatility, reports this update. See why Molina Healthcare ...

AppFolio remains a buy, with >20% growth expected, driven by premium tier upgrades and accelerating AI adoption. APPF’s ...

ETW has shifted its option overwrite strategy from nearly 100% to under 50% with the latest update. Find out why ETW CEF is a Buy.

Forward Air faces significant margin deterioration and high net debt leverage. Read what makes FWRD stock a high-risk, ...

Comus Investment, LLC reports a 43.43% net return for 2025 despite restrictions on Hong Kong equities. Read the full annual ...

Escalating US-EU tensions over Greenland have triggered aggressive US tariff threats. Read why I am avoiding US Treasuries.

Leaven Partners gained 4.2% in Q4 2025, significantly outperforming indices through a tactical yen hedge. Access the full ...

Neuberger High Yield Strategies' 14.9% yield is attractive, but net investment income consistently falls short of ...

NextNRG's mobile fuel delivery drives strong revenue growth, yet gross margins remain low. Read why I view NXXT as a ...

Trump’s proposed Board of Peace would grant permanent seats for $1B, with Trump as chairman overseeing Gaza rebuilding funds.